首页 | 本学科首页   官方微博 | 高级检索  
     


First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt
Authors:Mohamed Al-Agamy Mohamed Hamed  El-Din Ashour Mohamed Seif  Wiegand Irith
Affiliation:

aDepartment of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt

bPharmaceutical Microbiology, University of Bonn, Meckenheimer Allee 168, 53115 Bonn, Germany

Abstract:We studied the presence of β-lactamases with an extended spectrum of activity in clinical Escherichia coli isolates from Cairo, Egypt. Forty-six E. coli isolates were collected from patients with urinary tract infections at a university hospital in 2001. Phenotypic characterisation identified a very high extended-spectrum β-lactamase (ESBL) rate of 60.9%. Pulsed-field gel electrophoresis and plasmid profiles revealed eight different clonal groups. All ESBL producers were polymerase chain reaction-positive for blaTEM and blaCTX-M genes. Within the CTX-M family, three different enzymes, CTX-M-14, CTX-M-15 and CTX-M-27, were found. The ESBL producers carried multiple plasmids and further plasmid-encoded resistances. In several strains, genes for up to six aminoglycoside-modifying enzymes were detected. A linkage to fluoroquinolone resistance was not observed. This study confirms the high rate of ESBLs in Egypt and further demonstrates the worldwide spread of genes coding for CTX-M enzymes in clinical isolates.
Keywords:Egypt   Escherichia coli   β-Lactamase   CTX-M   Multiresistance
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号